FADS2 and psoriasis: Among various contributing factors, lipid metabolic reprogramming, particularly PUFA metabolism, has emerged as a pivotal factor in disease progression.[16] In this study, we identified FADS2 as a key metabolic regulator of inflammation in psoriasis.